0001209191-23-037043.txt : 20230614 0001209191-23-037043.hdr.sgml : 20230614 20230614163527 ACCESSION NUMBER: 0001209191-23-037043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230612 FILED AS OF DATE: 20230614 DATE AS OF CHANGE: 20230614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Soni Manmeet Singh CENTRAL INDEX KEY: 0001569769 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 231014608 MAIL ADDRESS: STREET 1: C/O PHARMACYCLICS, INC. STREET 2: 995 EAST ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 BUSINESS PHONE: 972-865-2219 MAIL ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-12 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001569769 Soni Manmeet Singh 5320 LEGACY DRIVE PLANO TX 75024 0 1 0 0 COO, CFO and President 0 Class A common stock 2023-06-12 4 S 0 4711 99.6173 D 111461 D Class A common stock 2023-06-13 4 M 0 25000 27.32 A 136461 D Class A common stock 2023-06-13 4 S 0 9326 99.7473 D 127135 D Class A common stock 2023-06-13 4 S 0 9157 101.0537 D 117978 D Class A common stock 2023-06-13 4 S 0 16163 101.9847 D 101815 D Class A common stock 2023-06-13 4 S 0 3643 102.7251 D 98172 D Class A common stock 2023-06-13 4 S 0 25530 104.0892 D 72642 D Class A common stock 2023-06-13 4 S 0 14016 105.0485 D 58626 D Class A common stock 2023-06-13 4 S 0 250 105.55 D 58376 D Employee Stock Option (right to buy) 27.32 2023-06-13 4 M 0 25000 0.00 D 2032-01-03 Class A common stock 25000 75000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $99.50 to $99.92 The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $99.50 to $100.4745. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $100.496 to $101.44. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $101.48 to $102.44. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $102.4807 to $102.995. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $103.51 to $104.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $104.515 to $105.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The options vest in sixteen equal quarterly installments beginning on April 3, 2022, subject to continued service through each vesting date. /s/ Tracy Herson, attorney-in-fact 2023-06-14